REGENXBIO Inc. Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENXBIO Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENXBIO Inc. for January 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 6,500 | 5,525 | 41,170 | |
| Jan 27 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 44.99 | 5,211 | 234,443 | 280,984 | 286.2 K to 281 K (-1.82 %) |
| Jan 27 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 44.05 | 974 | 42,905 | 286,195 | 287.2 K to 286.2 K (-0.34 %) |
| Jan 27 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 42.64 | 315 | 13,432 | 287,169 | 287.5 K to 287.2 K (-0.11 %) |
| Jan 27 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 6,500 | 5,525 | 287,484 | 281 K to 287.5 K (+2.31 %) |
| Jan 20 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 50.04 | 252 | 12,610 | 113,640 | 113.9 K to 113.6 K (-0.22 %) |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Option Exercise | M | 35.80 | 10,372 | 371,318 | 17,128 | |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Option Exercise | M | 19.50 | 1,240 | 24,180 | 0 | |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Option Exercise | M | 19.50 | 1,700 | 33,150 | 1,240 | |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Sell | S | 50.01 | 11,612 | 580,716 | 17,748 | 29.4 K to 17.7 K (-39.55 %) |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Buy | M | 35.80 | 10,372 | 371,318 | 29,360 | 19 K to 29.4 K (+54.62 %) |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Buy | M | 19.50 | 1,240 | 24,180 | 18,988 | 17.7 K to 19 K (+6.99 %) |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Sell | S | 50.03 | 1,700 | 85,051 | 17,748 | 19.4 K to 17.7 K (-8.74 %) |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Buy | M | 19.50 | 1,700 | 33,150 | 19,448 | 17.7 K to 19.4 K (+9.58 %) |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 50.03 | 11,093 | 554,983 | 113,892 | 125 K to 113.9 K (-8.88 %) |
| Jan 14 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 50.01 | 4,200 | 210,042 | 124,985 | 129.2 K to 125 K (-3.25 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 19.50 | 1,378 | 26,871 | 641 | |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 19.50 | 2,622 | 51,129 | 2,019 | |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 12.10 | 7,500 | 90,750 | 22,431 | |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 12.10 | 10,000 | 121,000 | 29,931 | |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 49.15 | 1,378 | 67,729 | 16,372 | 17.8 K to 16.4 K (-7.76 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 19.50 | 1,378 | 26,871 | 17,750 | 16.4 K to 17.8 K (+8.42 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 49.08 | 10,122 | 496,788 | 16,372 | 26.5 K to 16.4 K (-38.20 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 19.50 | 2,622 | 51,129 | 26,494 | 23.9 K to 26.5 K (+10.98 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 12.10 | 7,500 | 90,750 | 23,872 | 16.4 K to 23.9 K (+45.81 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 48.13 | 1,320 | 63,532 | 16,372 | 17.7 K to 16.4 K (-7.46 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 47.42 | 4,062 | 192,620 | 17,692 | 21.8 K to 17.7 K (-18.67 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 46.43 | 4,618 | 214,414 | 21,754 | 26.4 K to 21.8 K (-17.51 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 12.10 | 10,000 | 121,000 | 26,372 | 16.4 K to 26.4 K (+61.08 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 19.50 | 1,378 | 26,871 | 641 | |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 19.50 | 2,622 | 51,129 | 2,019 | |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 12.10 | 7,500 | 90,750 | 22,431 | |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 12.10 | 10,000 | 121,000 | 29,931 | |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 49.15 | 1,378 | 67,729 | 16,372 | 17.8 K to 16.4 K (-7.76 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 19.50 | 1,378 | 26,871 | 17,750 | 16.4 K to 17.8 K (+8.42 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 49.08 | 10,122 | 496,788 | 16,372 | 26.5 K to 16.4 K (-38.20 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 19.50 | 2,622 | 51,129 | 26,494 | 23.9 K to 26.5 K (+10.98 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 12.10 | 7,500 | 90,750 | 23,872 | 16.4 K to 23.9 K (+45.81 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 48.13 | 1,320 | 63,532 | 16,372 | 17.7 K to 16.4 K (-7.46 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 47.42 | 4,062 | 192,620 | 17,692 | 21.8 K to 17.7 K (-18.67 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 46.43 | 4,618 | 214,414 | 21,754 | 26.4 K to 21.8 K (-17.51 %) |
| Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 12.10 | 10,000 | 121,000 | 26,372 | 16.4 K to 26.4 K (+61.08 %) |
| Jan 11 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Option Exercise | M | 19.50 | 5,185 | 101,108 | 2,940 | |
| Jan 11 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Sell | S | 50.01 | 5,185 | 259,302 | 17,748 | 22.9 K to 17.7 K (-22.61 %) |
| Jan 11 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Buy | M | 19.50 | 5,185 | 101,108 | 22,933 | 17.7 K to 22.9 K (+29.21 %) |
| Jan 11 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 48.15 | 573 | 27,590 | 129,185 | 129.8 K to 129.2 K (-0.44 %) |
| Jan 11 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 47.49 | 2,208 | 104,858 | 129,758 | 132 K to 129.8 K (-1.67 %) |
| Jan 11 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 46.45 | 2,460 | 114,267 | 131,966 | 134.4 K to 132 K (-1.83 %) |
| Jan 11 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 50.00 | 10,998 | 549,900 | 134,426 | 145.4 K to 134.4 K (-7.56 %) |
| Jan 11 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 1,500 | 1,275 | 47,670 | |
| Jan 11 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 50.01 | 1,500 | 75,015 | 281,984 | 283.5 K to 282 K (-0.53 %) |
| Jan 11 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 1,500 | 1,275 | 283,484 | 282 K to 283.5 K (+0.53 %) |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | A | 44.97 | 56,200 | 2,527,314 | 56,200 | |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Grant | A | 0.00 | 12,400 | 0 | 145,424 | 133 K to 145.4 K (+9.32 %) |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Option Exercise | A | 44.97 | 62,300 | 2,801,631 | 62,300 | |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Grant | A | 0.00 | 13,800 | 0 | 17,748 | 3.9 K to 17.7 K (+349.54 %) |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | PAKOLA STEVE | Chief Medical Offic ... | Option Exercise | A | 44.97 | 49,700 | 2,235,009 | 49,700 | |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | PAKOLA STEVE | Chief Medical Offic ... | Grant | A | 0.00 | 11,000 | 0 | 11,000 | 0 to 11 K |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | A | 44.97 | 52,500 | 2,360,925 | 52,500 | |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Grant | A | 0.00 | 11,600 | 0 | 19,043 | 7.4 K to 19 K (+155.85 %) |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Grant | A | 31.31 | 641 | 20,067 | 7,443 | 6.8 K to 7.4 K (+9.42 %) |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Grant | A | 34.82 | 302 | 10,517 | 6,802 | 6.5 K to 6.8 K (+4.65 %) |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | A | 44.97 | 62,500 | 2,810,625 | 62,500 | |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Grant | A | 0.00 | 13,800 | 0 | 16,372 | 2.6 K to 16.4 K (+536.55 %) |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | A | 44.97 | 185,167 | 8,326,960 | 185,167 | |
| Jan 06 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Grant | A | 0.00 | 40,984 | 0 | 281,984 | 241 K to 282 K (+17.01 %) |